Direct-to-consumer healthcare. We see it more and more, and it is an increasing trend that’s been written about extensively (see: health-tech business models, the B2C2B playbook, amongst others). Today we want to take a step back and discuss some philosophical implications and the ethical/ safety concerns we think about as investors. And of course, we try never to wax poetic – skip to the end for actionable take-aways that you can use as a founder. Some lessons here translate globally but healthcare is very different in different parts of the world and this post is really focused on the US…....
D2C (direct to consumer) health-tech: How do we help, not hurt, our patients?
3 min read